Forget the cash ISA! I’d buy this FTSE 100 dividend bargain today

This former FTSE 100 (INDEXFTSE: UKX) darling has fallen on hard times, but this could be the perfect opportunity for savvy investors, writes Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Reckitt Benckiser (LSE: RB) used to be one of the FTSE 100’s most sought after companies, but that began to change in 2017.

Soon after shares in the consumer goods giant hit their all-time high of 8,100p in June 2017, cracks started to appear in Reckitt’s business model as its $17bn deal to buy Mead Johnson, the US-based infant formula business, went sour.

Growth ground to a halt and the company suffered a series of operational disappointments, which shook investor confidence. These problems have claimed the head of former CEO Rakesh Kapoor, who is stepping down. He will be replaced by Laxman Narasimhan, who is set to take over in September. 

Narasimhan will have his work cut out to restore investor confidence. After earnings growth of just 2.3% in 2018, City analysts are forecasting almost no growth in 2019. Although there’s an earnings uptick of 5.4% pencilled in for 2020, that’s a substantial reduction on the earnings growth rates of 13% to 18% reported between 2015 and 2017. 

Moving on

Even though growth has slowed, Reckitt is working hard to move on from its issues. The central pillar of the firm’s turnaround is the separation of Reckitt’s two primary businesses, health, and hygiene and household products. This separation will, management believes, help refine the business’s focus and ultimately drive growth. 

Also Reckitt announced today it has agreed a $1.4bn settlement with the US Department of Justice and the Federal Trade Commission regarding an investigation into how its former subsidiary, Indivior (LSE: INDV), marketed Suboxone, its flagship opioid addiction treatment drug. 

Limiting liabilities

Reckitt had set aside $400m to cover any liabilities stemming from its association with Indivior, and while the company itself hasn’t been charged, there’s been a looming threat that the group could be dragged into Indivior’s legal woes at a later date. Indivior is facing at least $3bn in fines over allegations it committed fraud from 2006 to 2015 by making unfounded claims about the potential of Suboxone to drive up sales. 

Indivior is still facing these legal claims, and it could be some time before any settlement is announced. With a market-cap of just £323m, or around $400m at present, there’s a very real chance these claims could bankrupt the company, so I’d stay away from this firm for the time being.

That said, the fact Reckitt has been able to agree a settlement is a positive development for the firm. This has increased the odds that Indivior will be able to do the same, although I wouldn’t bet on it at this stage. 

Time to buy

Meanwhile, now the consumer goods giant has put this issue behind it, I think Reckitt’s fortunes are improving. As a result, now could be the time to snap up shares in this business at a bargain price.

At the time of writing, the stock is trading at a forward P/E of just 18, below its five-year average of 22. On top of that, the stock supports a dividend yield of 2.7%, the payout is covered twice by earnings per share and has grown at a compound annual rate of 5% for the past six years

So, overall, if you’re looking to add a defensive income stock to your portfolio at an attractive price, I highly recommend taking a closer look at Reckitt. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Dividend Shares

£3k in savings? Investors could consider putting it here for juicy second income

Jon Smith talks through how investors could buy dividend stocks with yield potential in excess of 6.5% for second income

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

Why the boohoo share price soared by almost 14% in November

Is troubled online fashion retailer boohoo beginning a turnaround that may cause the share price to rocket through 2025 and…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Here’s how saving £5.40 a day could net me £1,971 yearly passive income for life

The price of a cup of coffee seems to have broken the £5 mark. Is it time to put that…

Read more »

Investing Articles

2 top FTSE 100 stocks surging to record highs (hint — not Rolls-Royce)!

Ben McPoland takes a closer look at a pair of high-performing FTSE 100 stocks that continue to enrich long-term shareholders.

Read more »

Investing Articles

A cheap FTSE 100 share to consider buying for the next 10 years!

This FTSE 100 share has pride of place in my portfolio. Here's why I think it could be a top…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Down 44% in 2 months! Is this FTSE 250 green energy pioneer priced too cheaply?

After a sharp tumble in recent months, this FTSE 250 company with a growing order book is almost 90% below…

Read more »

Investing Articles

Investing a £20k Stocks and Shares ISA in this high-yielder might give me a £2,000 annual income

Harvey Jones is now wondering whether to pour his entire Stocks and Shares ISA allowance into a single FTSE 100…

Read more »

Investing Articles

Saving £20k in an ISA? Here’s how I’m aiming to turn that into a stunning £2,035 monthly passive income

Harvey Jones is keen to build a high and rising passive income by investing in a balanced spread of top…

Read more »